§300b–12 — Title 42 The Public Health and Welfare | U.S. Code

Summary

The Secretary must have the CDC director, after consulting the Advisory Committee on Heritable Disorders in Newborns and Children (created under section 300b–10), run programs that keep newborn and child screening labs working well. These programs must include lab test quality checks, faster test processing, performance evaluations, technical help, and supplying control materials for new screening tools. The CDC director may also help coordinate monitoring by standardizing how data are collected and reported, using electronic health records, and encouraging data sharing with State birth-defects and developmental-disability tracking programs.

Title 42, §300b–12

The Public Health and Welfare — Source: USLM XML via OLRC

(a)The Secretary, acting through the Director of the Centers for Disease Control and Prevention and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title, shall provide for—

(1)quality assurance for laboratories involved in screening newborns and children for heritable disorders, including quality assurance for newborn-screening tests, timeliness for processing such tests, performance evaluation services, and technical assistance and technology transfer to newborn screening laboratories to ensure analytic validity and utility of screening tests; and

(2)appropriate quality control and other performance test materials to evaluate the performance of new screening tools.

(b)The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title, may provide, as appropriate, for the coordination of surveillance activities, including—

(1)through standardized data collection and reporting, as well as the use of electronic health records; and

(2)by promoting data sharing regarding newborn screening with State-based birth defects and developmental disabilities monitoring programs.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2014—Pub. L. 113–240, § 6(1), inserted “and surveillance” after “quality” in section catchline. Subsec. (a). Pub. L. 113–240, § 6(2)(A), substituted “and taking into consideration the expertise of the Advisory Committee” for “and in consultation with the Advisory Committee” in introductory provisions. Subsec. (a)(1). Pub. L. 113–240, § 6(2)(B), inserted “timeliness for processing such tests,” after “newborn-screening tests,”. Subsec. (b). Pub. L. 113–240, § 6(3), added subsec. (b) and struck out former subsec. (b). Prior to amendment, text read as follows: “For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for fiscal year 2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.” 2008—Subsec. (b). Pub. L. 110–237 substituted “2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013.” for “2008, $5,062,500 for fiscal year 2009, $5,125,000 for fiscal year 2010, $5,187,500 for fiscal year 2011, and $5,250,000 for fiscal year 2012.”

§300b–12 Laboratory quality and surveillance

Summary

Title 42, §300b–12

Notes & Related Subsidiaries

Editorial Notes

Amendments

Citations & Metadata